ADIM
EVRI

Alpha DNA Investment Management’s Everi Holdings EVRI Stock Holding History

Alpha DNA Investment Management’s Portfolio EVRI Stock Details EVRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-56,208
Closed -$1.18M – 135
2022
Q1 		$1.18M Sell
56,208
-14,699
-21% -$313K 0.83% 79
2021
Q4 		$1.51M Buy
+70,907
New +$1.62M 0.95% 68
2021
Q3 		– Sell
-58,862
Closed -$1.47M – 120
2021
Q2 		$1.47M Buy
+58,862
New +$1.11M 1% 47

Other funds holding EVRI

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alpha DNA Investment Management's EVRI Position: Q2 2022 in Review

Alpha DNA Investment Management sold out of Everi Holdings (EVRI) in Q2 2022, closing a stake of 56,208 shares — an estimated $1.18M sold.

Alpha DNA Investment Management first reported a position in EVRI in Q2 2021 and held it in 3 quarters. The position peaked at $1.51M in Q4 2021. 220 funds tracked by Wall St. Rank hold EVRI as of Q2 2022.

  • Alpha DNA Investment Management reported no remaining Everi Holdings position as of Q2 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 56,208 Everi Holdings shares in Q2 2022, an estimated $1.18M.
  • Alpha DNA Investment Management first reported a position in Everi Holdings in Q2 2021 and held it in 3 quarters.
  • Alpha DNA Investment Management's Everi Holdings position peaked at $1.51M in Q4 2021.
  • 220 funds tracked by Wall St. Rank held Everi Holdings as of Q2 2022.

Based on Alpha DNA Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.